Back |
home / stock / hrtx / hrtx message board
Subject | By | Source | When |
---|---|---|---|
danrocks: HRTX Stock is number 103 for the largest percentage gain out of 250 stocks. $HRTX HRTX is | danrocks | investorshangout | 03/10/2015 4:10:35 PM |
danrocks: HRTX Stock is number 125 for the largest percentage gain out of 250 stocks. $HRTX HRTX is | danrocks | investorshangout | 03/09/2015 4:29:24 PM |
danrocks: HRTX Stock is number 61 for the largest percentage gain out of 250 stocks. $HRTX HRTX is u | danrocks | investorshangout | 03/06/2015 4:27:57 PM |
chartguy89: HRTX 15.47 Heron Therapeutics Inc. Stock Charts $HRTX Last Updated: 03/05/15 Last price: | chartguy89 | investorshangout | 03/06/2015 7:26:33 AM |
Jake13: HRTX Stock year to date has changed +39.36% percent. +72.24% in the last 30 days. $HRTX Hero | Jake13 | investorshangout | 03/05/2015 6:42:35 AM |
News, Short Squeeze, Breakout and More Instantly...
Heron Therapeutics Inc. Company Name:
HRTX Stock Symbol:
NASDAQ Market:
Heron Therapeutics Inc. Website:
Heron Therapeutics to Report Second Quarter 2024 Financial Results On Tuesday, August 6, 2024 PR Newswire SAN DIEGO , July 30, 2024 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company, today announced that the company...
Heron Therapeutics Announces the Inclusion of ZYNRELEF® as a Qualifying Product Under the Proposed 2025 Non-Opioid Policy for Pain Relief Under the OPPS and the ASC Payment System PR Newswire SAN DIEGO , July 15, 2024 /PRNewswire/ -- Heron Therapeutics, Inc....
Heron Therapeutics Announces Acceptance of the Prior Approval Supplement Application for ZYNRELEF® Vial Access Needle ("VAN") PR Newswire -The U.S. Food and Drug Administration ("FDA") assigned a Prescription Drug User Fee Act ("PDUFA") goal date of September 23, 2024 ...